{{Rsnum
|rsid=7291467
|Gene=LGALS2
|Chromosome=22
|position=37576621
|Orientation=plus
|GMAF=0.4389
|Gene_s=LGALS2,LOC100652769
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.1 | 44.6 | 12.3
| HCB | 4.4 | 44.4 | 51.1
| JPT | 11.4 | 40.9 | 47.7
| YRI | 4.8 | 47.6 | 47.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 44.4 | 51.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20500087
|Title=Age-Related Susceptibility to Severe Malaria Associated with Galectin-2 in Highland Papuans
|OA=1
}}

{{PMID Auto
|PMID=22310064
|Title=Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: a pathological study of 1503 consecutive autopsy cases
}}

{{PMID Auto
|PMID=16468038
|Title=Genotype of galectin 2 (LGALS2) is associated with insulin-glucose profile in the British Women's Heart and Health Study.
}}

{{PMID Auto
|PMID=17098239
|Title=LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians.
}}

{{PMID Auto
|PMID=17517687
|Title=Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans.
}}

{{PMID Auto
|PMID=17767904
|Title=Genetic and genomic insights into the molecular basis of atherosclerosis.
|OA=1
}}

{{PMID Auto
|PMID=18506375
|Title=Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome.
}}

{{PMID Auto
|PMID=21831908
|Title=Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis.
}}

[[Coronary Heart Disease]]

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}